Amrutanjan Health Care Limited (AMRUTANJAN) Financial History

Name: Amrutanjan Health Care Limited (AMRUTANJAN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Amrutanjan Health Care Limited (AMRUTANJAN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chennai, India with about 661 employees. Its market capitalization is roughly ₹14 billion. In the fiscal year ended 2026-03-31, AMRUTANJAN reported ₹5.0B in revenue and ₹579M in net income.

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene & Personal Care, and Others segments.

Interactive charts & full statements →

AMRUTANJAN Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹5.0B	₹4.5B	₹4.2B	₹3.8B
Gross Profit	₹2.6B	₹2.3B	₹2.1B	₹2.0B
Operating Income (EBIT)	₹710M	₹536M	₹480M	₹421M
Net Income	₹579M	₹508M	₹450M	₹398M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMRUTANJAN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2024-12-31
Total Revenue	₹1.0B	₹1.5B	₹1.4B	₹1.2B	₹940M	—
Gross Profit	₹487M	₹762M	₹772M	₹600M	₹447M	—
Operating Income (EBIT)	₹23M	₹163M	₹235M	₹150M	₹69M	—
Net Income	₹44M	₹162M	₹194M	₹140M	₹83M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMRUTANJAN Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹132M)	(₹133M)	(₹134M)	(₹144M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMRUTANJAN Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	₹5.1B	₹4.2B	₹3.7B	₹3.6B
Total Liabilities	₹1.4B	₹948M	₹784M	₹713M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AMRUTANJAN viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

0512 · Grand Pharmaceutical Group Limited — HK$17 billion
3933 · The United Laboratories International Holdings Limited — HK$16 billion
2637 · Fujian Haixi Pharmaceuticals Co., Ltd. — HK$15 billion
JAGSNPHARM · Jagsonpal Pharmaceuticals Limited — ₹15 billion
FERMENTA · Fermenta Biotech Limited — ₹14 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — JPY 13 billion
IPN · Ipsen S.A. — €13 billion
AHCL · Anlon Healthcare Limited — ₹12 billion

← AMRN All “A” companies AMRX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.